Plaintiffs file support of US Supreme Court review of Merck mumps vaccines antitrust case
( October 2, 2025, 20:57 GMT | Official Statement) -- MLex Summary: Plaintiffs accusing Merck of unlawfully extending its monopoly over mumps vaccines by making false drug-label claims filed a reply in support of their petition for the US Supreme Court to review their case and rule that successfully deceiving the government does not confer immunity from antitrust liability. They argued that all other circuits to have addressed the question agree that the approach adopted by the Third Circuit in their case is wrong, and Merck barely attempts to defend the court’s approach as consistent with first principles or precedent.See attached file....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.